Announced
Completed
BRIDGEBIO PHARMA LLC / VIKING GLOBAL OPPORTUNITIES / PERCEPTIVE LIFE SCIENCES / KKR & CO / JANUS CAPITAL MANAGEMENT LLC / AISLING CAPITAL LLC / AIG ASSET MANAGEMENT (U.S.) LLC / Acquisition / Private
Synopsis
Equity investment by KKR Genetic Disorder in BridgeBio Pharma, a developer of precision medicinal therapies for the treatment of genetic pediatric diseases.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.